theravance inc (THRX:NASDAQ GS)

Executive Profile*

Background*

Mr. Michael W. Aguiar has been the Chief Financial Officer and Senior Vice President of Finance at Theravance Inc. since March 7, 2005 and serves as Principal Accounting Officer. Previously, Mr. Aguiar served as Vice President of Finance at Gilead Sciences. In his two years as Gilead's Vice President of Finance, Mr. Aguiar managed approximately 100 finance professionals in nine countries. In this capacity, he was responsible for Gilead's Controllership, Treasury, Financial ... Planning & Analysis, Tax, SEC reporting, Risk Management, and Business Unit Finance. He has significant business transaction experience, most recently on Gilead's acquisition of Triangle Pharmaceuticals, has led financings, and oversaw significant portions of Gilead's Sarbanes-Oxley Section 404 implementation efforts. Prior to Gilead, he held a similar position at Immunex Corporation in Seattle. Before working in the healthcare industry, he spent six years with Honeywell International in a variety of financial positions of increasing responsibility, including, most recently, Chief Financial Officer and Vice President of Finance at Honeywell Electronic Materials. Mr. Aguiar earned a BS in biology from UC Irvine and an MBA in finance from the University of Michigan.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
THRX:US	$36.24 USD	-0.54

COMPETITOR COMPENSATION